Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

Wolfram Pönisch, Paris S. Mitrou, K Merkle, Michael Herold, G. Wilhelm, Klaus Dachselt, Peter C. Richter, Veronika Schirmer, Antina Schulze, R. Šubert,

Journal of Cancer Research and Clinical Oncology · 2006 · 192 citations · 27 references

DOIFull text

Open access

Concepts

References

27